~~<i id='73A3DFB8F4'><strike id='73A3DFB8F4'><tt id='73A3DFB8F4'><pre id='73A3DFB8F4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：explore 2025-09-30 17:45:21 - browse：36

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： US soldier in North Korean custody after crossing DMZ line

knowledge

leisure time

entertainment

JustinKlee,left,andJoshuaCohen,bothco-foundersandco-CEO'sofAmylyxPharmaceuticals.KayanaSzymczakforST

WSS

A Theranos scientist

RaDonda Vaught to speak at CommonSpirit event on patient safety

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Pfizer highlights cancer drugs it thinks could reignite investor interest

Flu vaccine offering decent levels of protection this winter, new data show

Flu vaccine offering decent levels of protection this winter, new data show

focus

comprehensive

knowledge

Drug repurposing or repositioning? The language matters

RaDonda Vaught to speak at CommonSpirit event on patient safety

In age of alternative facts, a scholarly course on calling out crap

Study: Hearing aids may slow cognitive decline in those at risk

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

In Memoriam: Notable people who died in 2023

In search for therapies for solid tumors, companies turn to claudin

Psychedelics group wrestles with new pharma identity

A look at other Americans who have crossed into North Korea over the years

leisure time

Manchin plays down potential 3rd

FDA seeking to stop procedures at two unregulated stem cell clinics

Why you get paid to donate plasma but not blood

Obesity now affects over 1 billion people worldwide, study finds

Obesity now affects over 1 billion people worldwide, study finds

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

leisure time

leisure time

entertainment

entertainment